☆ 4.7 Letter

Liquid biopsy identifies actionable dynamic predictors of resistance to Trastuzumab Emtansine (T-DM1) in advanced HER2-positive breast cancer

MOLECULAR CANCER (2021)

Get Full Text
Add to Collection

Journal

MOLECULAR CANCER
Volume 20, Issue 1, Pages -

Publisher

BMC
DOI: 10.1186/s12943-021-01438-z

Keywords

HER2(+) breast cancer; T-DM1; Liquid biopsy; Circulating tumor DNA; Pharmacological resistance

Categories

Biochemistry & Molecular Biology Oncology

Funding

  1. Associazione Italiana per la Ricerca sul Cancro (AIRC, Nuvenia Fellowship) [19503]
  2. H2020 EU project ULTRAPLACAD [633937]
  3. LazioInnova ERBB2-2D project [A0375-2020-36630]
  4. IRCCS Regina Elena Scientific Direction intramural funding

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.